The cardiac gene regulatory network (GRN) is controlled by transcription factors and signaling inputs, but network logic in development and it unraveling in disease is poorly understood. In development, the membrane-tethered signaling ligand Neuregulin (Nrg)1, expressed in endocardium, is essential for ventricular morphogenesis. In adults, Nrg1 protects against heart failure and can induce cardiomyocytes to divide.
A n early patterning event in vertebrate heart development is the specification of myocardium of the atrial and ventricular chambers, a specialized muscle adapted to pumping blood through a closed circulatory system at high pressure. 1 Luminal myocytes of the cardiac chambers develop sponge-like convolutions termed trabeculae, which in development serve as a morphological marker for chamber specification. The trabecular zone is also marked by a unique set of genes. Chamber muscle is an electric syncytium through which action potentials spread via gap junctions, guided by caudal pacemaker myocytes and their conduction and Purkinje fiber tracts.
Nontrabecular myocardium of the atrium, inner curvature, atrioventricular (AV) canal and outflow tract (OFT) is less specialized for contraction and gives rise to the myogenic layers of the outflow and inflow vessels, and cells of the proximal conduction system including the sinoatrial (SA) and AV nodes. 1 Nontrabecular myocardium also plays a critical role in induction and patterning of the endocardial cushions and heart valves. 2 Myocardium of the left ventricle (LV) is initially specified in a discrete ventral territory in the forming mouse heart tube at 8.0 days postcoitum (dpc), becoming positioned at the outer curvature of the heart as it undergoes looping. 3 Working myocardium of the right ventricle (RV) is specified slightly later (Ϸ8.5 dpc) as its precursor cells are deployed from the second heart progenitor field. 4 The atrial appendages are specified by Ϸ9.5 dpc as distinct caudolateral territories within the forming common atrium.
Trabecular and nontrabecular myocardium develop unique transcription factor signatures that are mutually antagonistic, allowing for creation and refinement of unambiguous territories and boundaries. 1 Hierarchies of T-box transcription factors underpin this antagonism. 5 Genetic and in vitro studies suggest that Tbx5 and Tbx20 are positive drivers of chamber and conduction system specification, whereas Tbx2 and Tbx3 are repressors expressed in nontrabecular myocardium, where they actively inhibit chamber fate. Bone morphogenetic protein (BMP) signaling is embedded within this hierarchy to reinforce further the separation of trabecular and nontrabecular myocardium. 6 T-box factors collaborate with other heart transcription factors, notably the homeodomain factor Nkx2-5, to control myocardial cell fates. 5 The primary heart tube is initially in a state of virtual quiescence, before myocytes within chamber territories expand by cellular growth and proliferation, as well as by addition of new myocytes from nontrabecular myocardium and potentially the epicardium. [7] [8] [9] Trabeculae, which manifest at the luminal (subendocardial) surface of chambers, are more developed electrically and structurally, reflected by the more advanced state of differentiation of sarcomeres, sarcoplasmic reticulum and intercalated discs. 10 They act initially as conduction tissue for fast propagation of action potentials to apical myocytes, thus ensuring an apex-to-base mode of contraction. 11 They also likely provide the force-generating component of the embryonic heart and an increased surface area for oxygen and nutrient exchange before formation of the coronary circulation. Trabeculae have their origins in the subepicardial layer, 11 but become largely quiescent, 12 persisting to give rise to the bundle branches and Purkinje fibers of the ventricular conduction system, as well as papillary muscles of the AV valves. 11 Elaboration of the trabecular network involves the Neuregulin (Nrg)1 signaling axis. Nrg1 is a member of the epidermal growth factor (EGF) family of ligands and is expressed in the endocardial layer downstream of Notch and EphrinB2 signaling. 13 Directly secreted and cleaved transmembrane Nrg1 isoforms diffuse through the extracellular matrix and signal to myocardium via the ErbB-family tyrosine kinase receptor ErbB4 and its coreceptor ErbB2. 14 In mice null for Nrg1 or either of its myocardial receptors, the heart tube forms and loops normally, but trabeculation is blocked. 15 Conversely, the delivery of recombinant Nrg1 to the developing heart leads to hypertrabeculation 12 and accelerates maturation of a functional Purkinje fiber network. 16 In ventricular cardiomyocyte cultures, Nrg1 induces expression of cardiac differentiation and conduction tissue genes. 17 In the adult heart, Nrg1 is expressed in the endocardium and coronary microvasculature and protects the heart against failure and premature death. 18 It can also stimulate reentry of cardiomyocytes into the cell cycle. 19 Although signaling pathways downstream of Nrg1 and ErbB receptors have been characterized, 14, 15 how Nrg1 signaling impacts on heart morphogenesis and gene expression is unknown. Here, we report the creation of an extreme hypomorphic Nrg1 mutant model, and explore the impact of modulated Nrg1 on the cardiac gene regulatory network (GRN) and chamber specification. We show that Nrg1-ErbB2/4-Erk1/2 signaling sustains the GRN in both trabecular and nontrabecular myocardium and that transcriptional decay patterns induced by reduced Nrg1 reveal a novel mechanism of cardiac regulation likely linking biomechanical feedback to heart growth and differentiation.
Methods
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Animal Experiments
Nrg1 TM vector was generated as described. 20 Gene targeting was conducted at the Scripps Research Institute (San Diego, Calif) using 129/Sv-CJ1 ES cells. The ErbB4 gt allele was generated during a gene trap screen 21 and carried an insertion within intron 17. Primers for validation of Nrg1 alleles are shown in Online Table III . Echocardiography was performed as described. 22 ECG in conscious mice were acquired and recorded using an implantable telemetry system (Model TA10EA-F20) and a DataquestART data acquisition system (Data Sciences International). ECG intervals were measured for each animal using AcqKnowledge software (BIOPAC Systems Inc). QT intervals were rate corrected using the formula (QTcϭQT/[RR/ 100] 1/2 ). 23 All animal experiments were approved by the Garvan/St Vincent's Hospital and Walter and Elize Hall Institute of Medical Research animal ethics committees.
Cell and Embryo Culture
Embryonic cardiomyocytes 24 and embryo explants 25 were cultured as described. Mitogen-activated protein kinase (MAPK) kinase (MEK) inhibitors PD98059 and U0126 were dissolved in DMSO and used at a final concentration of 50 mol/L.
Expression and Kinase Activation Analyses
Whole-mount in situ hybridization, 26 ErbB receptor phosphorylation and cdk4 kinase assays 24, 27 were as reported previously. 
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Statistical Analysis
All statistical analyses were performed with a 2-tailed, unpaired Student t test. A value of PϽ0.05 was considered significant.
Results
Nrg1 TM/TM Mice
Most Nrg1 isoforms are membrane tethered and are shed by proteolytic cleavage. 14 We created a new model of Nrg1 deficiency in which the exon encoding the transmembrane (TM) domain of membrane-bound isoforms was exchanged for an oligonucleotide containing stop codons in all three frames and a bovine growth hormone mRNA termination sequence ( Figure 1A and 1B). This change was designed to allow for continued expression of directly secreted isoforms and, potentially, the secretion of isoforms normally tethered to the membrane. Germline mice were outcrossed to the C57BL/6J strain. Correct targeting was confirmed in knockout embryos using PCR and Southern blotting ( Figure 1C ). Targeted modifications did not interfere with transcription from the 2 known cardiac Nrg1 promoters 28 : wild-type levels of transcripts encoding type I isoforms were readily detected, as were type III transcripts, including those encoding the directly secreted Nrg1␤3 isoform ( Figure 1D and 1E). 14
Chamber Disruption in Nrg1 TM/TM Embryos
Heterozygous Nrg1 TM/ϩ mice thrived and were fertile, albeit with schizophrenia-like behavioral affectations as previously published. 14 Nrg1 TM/TM embryos appeared normal until 9.0 dpc but were dysmorphic at 10 to 10.5 dpc and died before 11.5 dpc with grossly abnormal cardiac morphogenesis. At 10.5 dpc, the morphological characteristics of the LV varied between individual mutants ( Figure 2A ). In least-affected (class I; 9%; C57Bl/6 background), the LV was of normal size although misshapen. In the majority (classes II and III; 31% and 60%, respectively; C57Bl/6 background), the LV was dilated, dramatically in class III embryos that showed poor head development and signs of systemic failure. Enlarged atria were evident in all Nrg1 TM/TM hearts at 10.5 dpc. At 10.5 dpc, when ventricular trabeculae were evident in wild type hearts, trabeculation in Nrg1 TM/TM hearts was severely impaired ( Figure 2B through 2E), as also seen in Nrg1 Ϫ/Ϫ null hearts. 29 The LV was more severely affected, being essentially smooth-walled in all mutant classes. Rudi- mentary trabeculae were present in the forming RV, most obviously in class I mutants (arrowheads, Figure 2D ). These have not been described in null embryos 29 ; therefore, we reexamined these and found a similar prevalence of RV trabecular rudiments (data not shown; Online Figure V, G; see also discussion regarding Nrg1 gt/gt embryos below).
Nrg1 is known to contribute to endocardial cushion formation. 15 As in null embryos, 29 AV canal (AVC) and OFT cushions of 9.5 to 10.5 dpc Nrg1 TM/TM hearts were severely underdeveloped ( Figure 2B through 2E). In approximately one-quarter of class II and III mutant hearts at 10.5 dpc, we also observed an inverted pocket of pericardium, myocardium, and endocardium within the LV (nϭ4/15; arrows, Online Figure  I The loss of trabeculae in Nrg1 TM/TM hearts was not attributable to apoptosis (Online Figure I, C). However, increased apoptosis was detected in the head in mutants at 10 dpc, and cranial ganglia were compromised, reflecting the role of Nrg1 in cranial neurogenesis. 14 We measured the proliferative index (percentage 5-bromodeoxyuridine-positive nuclei) of cardiomyocytes at the mitotically more active outer curvature of the ventricles at 9.5 dpc and found only a slight reduction in homozygotes (Online Figure I, B ), consistent with findings in Nrg1 null embryos. 13
Ventricular Conduction in Nrg1 TM/TM Hearts
Optical mapping studies in chick embryos show that ventricular contraction switches from an immature base-to-apex, to the mature apex-to-base pattern coincident with trabeculation and interventricular septation. 30 Acquisition of the apex-to-base pattern in the mouse occurs in two phases corresponding to development of the right then left bundle branches between 9.5 to 11.5 dpc, 16, 31 with comparable patterns seen in rat. 32 In mouse, culturing hearts in Nrg1 led to premature activation of a ventral conduction pathway. 16 Our observations of live embryos at 9.5 dpc showed apex-to-base muscular contractions in controls and, as expected, an abnormal base-to-apex pattern in Nrg1 TM/TM mutants propagating from the anterior surface of the AVC (nϭ10/18).
Chamber Formation in Nrg1 TM/TM Mutant Hearts
To explore changes in the transcriptional program in Nrg1 mutants, we determined the expression patterns of 15 genes using in situ hybridization in classes I and II Nrg1 TM/TM mutants. A LV transmural expression gradient has been observed for many cardiac genes, with highest levels in trabeculae. 33 This was evident here at 9.0 to 10.5 dpc for genes encoding transcription factors Nkx2-5, Hand1 and Cited1, myofilament proteins Mlc2v (Myl2) and Mlc2a (Myl7), cytoskeletal proteins Chisel (Smpx) and Sm22a (transgelin/Tagln), gap junction protein connexin 40 (Cx40/Gja5), and growth factor Bmp10 (Figures 3 and 4; Online Figure II ). Tbx20 transcripts display an opposing gradient, becoming more abundant with time in the outer compact layer. 25 In Nrg1 TM/TM mutant hearts at 9.0 to 10.5 dpc, all of the above genes were significantly downregulated in specific regional patterns. For Bmp10, which is a highly specific marker of early chamber specification and subsequently trabeculae, transcripts were globally downregulated (Online Figure II, A) . There appeared to be a low level of ectopic Bmp10 expression in mutants, perhaps because of perturbations in other regulatory or patterning factors. For other genes that specifically mark the forming ventricles and trabecular myocardium (Hand1, Smpx, and Gja5), expression was downregulated mostly at the central outermost part of the LV myocardium ( Figure 3A through 3C and Online Figure II , B, C, E, and F). Expression of chamber genes Smpx and Gja5 was retained in regions within or close to the AVC and interventricular groove.
For transcription factor genes with broader expression within the myocardium (Nkx2-5, Tbx20), transcripts were also lost selectively at the outermost curvature of the LV ( Figure 3D ; Online Figure II, D) and retained at robust levels in the RV, inner curvature, AVC, interventricular groove, and atria. The collapse of the program in mutants extended to myofilament genes Myl7 and Myl2, which encode cardiac myosin light chains, and Tagln, encoding the cytoskeletal regulatory protein SM22 ( Figure 3E through 3G). As for the other genes mentioned above, these myogenic and cytoskeletal genes were most significantly downregulated in the LV. The effect on expression of Actc1, which encodes ␣-cardiac actin, was particularly noteworthy. Actc1 is normally expressed in all regions of the developing myocardium, but enriched in trabeculae of the LV ( Figure 4A and 4B). In Nrg1 TM/TM hearts at 9.5 dpc, expression was downregulated at the outermost region of both the LV and RV, with robust expression retained at the interventricular groove, inner curvature, AVC, and atria ( Figure 4A and 4B). The above effects were not secondary to the inevitable systemic demise of mutant embryos, because expression of most genes was maintained at near normal levels in the RV and in noncardiac tissues (eg, Cited1 in the septum transversum, Hand1 in visceral and branchial mesoderm, Tbx20 in hindbrain and neural tube, and Gja5 in the vascular system; Online Figure II , B, C, D, and F).
For many genes, downregulation at 9.5 to 10.5 dpc may correlate with loss of trabeculae, which could be secondary to loss of expression of Bmp10, essential for trabecular growth. 34 However, this type of pattern did not hold for all genes examined. Irx4, encoding a member of the Iroquois family of transcription factors, is normally expressed in the myocardium of the ventricular region including both the trabecular and nontrabecular components and AVC. In Nrg1 TM/TM mutant hearts at 9.25 dpc, Irx4 expression was largely undetectable, although weak expression remained in the AVC ( Figure 4C and  4D ). An important conclusion, therefore, is that Nrg1 is required to maintain the cardiac transcription factor program in both trabecular and nontrabecular myocardium.
A representative group of genes marking the cardiac ventricles and conduction system (Gja1, Gja5, Irx4, Hand1, Smpx) were also tested by quantitative RT-PCR and all were markedly downregulated in Nrg1 TM/TM mutant hearts (Online Figure II , G).
Nrg1 Regulates Cardiac Gene Expression and Trabeculation in a Dose-Dependent Manner
Analysis of gene expression and morphology in Nrg1 TM/ϩ heterozygotes showed that the effects of reduced Nrg1 are dose-dependent. At 9.25 to 10.5 dpc, the expression levels of all genes tested (Bmp10, Cited1, Hand1, Tbx20, Smpx, Gja5, Nkx2-5, Myl2, Myl7, Tagln, Irx4, and Actc1) in the LV in Nrg1 TM/ϩ heterozygotes were intermediate between that seen in wild-type and homozygous hearts (Figures 3 and 4 ; Online Figure II) . The degree of LV trabeculation was also intermediate. Gene expression was often retained in trabeculae in heterozygotes and preferentially lost from the lessdifferentiated subepicardial layer of the LV (eg, patterns for Smpx and Myl2; Figure 3C and 3F). The responses of Irx4 and Actc1 in Nrg1 TM/ϩ heterozygotes were again noteworthy. As described, Irx4 is normally expressed in the ventricular region and in Nrg1 TM/TM hearts transcripts were lost throughout the heart from both the inner and outer curvatures (nontrabecular and trabecular components) ( Figure 4C and 4D). In Nrg1 TM/ϩ hearts, however, Irx4 expression was lost mostly from the outer curvature of the LV but was retained in the RV, inner curvature, interventricular region, and AVC ( Figure 4C and 4D). Actc1 behaved in a related but nonetheless distinct manner. As noted above, Actc1 expression in homozygotes showed downregulation at the outer regions of both the LV and RV. In heterozygotes, however, downregulation was evident only in the LV ( Figure 4A and 4B). These findings further reinforce the notion that transcriptional changes seen in homozygotes are not an indirect consequence of a premorbid state.
Nrg1 TM/ϩ heterozygotes nonetheless survived to adulthood and were healthy and fertile. To explore heart function in heterozygotes, we examined the ECG (ECG) and echocardiographic parameters of Nrg1 TM/ϩ mice at 40 to 50 weeks. We confirmed normal heart rate, wall thickness, chamber dimensions and ejection fraction (Online Table I ). The ECG of conscious Nrg1 TM/ϩ mice (nϭ16), measured using telemetry, showed normal His/Purkinje conduction parameters, although a pronounced prolongation of mean PR interval in both male and female heterozygotes was observed (Online Table II ; Online Figure III, A) . We also noted the sporadic occurrence of highly variable PR intervals over consecutive beats in approximately one third of animals (Online Figure III, B) , data consistent with poor differentiation of preferred conduction tracts within the AV node, which Cre recombinase lineage tracing suggests is derived from nontrabecular myocardium of the AVC. 35
Nrg1 Is Not Required for Chamber Specification
To address whether Nrg1 was required for specification of chambers in the developing heart, we examined diagnostic markers at stages before the onset of trabeculation. In normal embryos, Smpx and Nppa mark developing atrial and ventricular chambers. 3 In Nrg1 TM/TM mutant hearts at 9.0 to 9.5 dpc, Smpx was expressed in its normal domains and at relatively normal levels, although diminished expression in the LV was already evident (arrows, Online Figure IV, A) , supporting the notion that initial chamber specification was relatively normal. The evolution of Nppa expression followed an unexpected pattern. Nppa was initially expressed in the expected chamber-specific manner, but by 9.5 dpc transcripts were lost completely from the RV, although persisted at the outermost region of the LV (Figure 5A and 5B), a pattern reciprocal to that of other chamber markers. Nppa expression also showed striking upregulation and expansion in the atria ( Figure 5A and 5B) , with the level of expression in heterozygotes being intermediate between that seen in wildtype and homozygous hearts (data not shown). In the adult heart, Nppa is activated by myocardial wall stress, 25 induced (Nrg1-independent) stress response of biomechanical or metabolic origin (see Discussion).
The expression of Tbx2, which marks nontrabecular myocardium of the inner curvature, AVC and OFT, was normal in Nrg1 TM/TM hearts at 10.0 dpc (Online Figure IV, B) , again suggesting normal chamber demarcation. However, not all chamber markers displayed a normal pattern. Cited1 and Hand1 are first expressed in ventricular chamber primordia at the outer curvature of the newly formed heart tube. Cited1 is genetically downstream of Hand1, which, together with Hand2, is critical for chamber growth and survival. 36 Robust expression of Cited1 was not established in Nrg1 TM/TM hearts at 8.5 dpc even though normal transcript levels were seen in other parts of the embryo ( Figure 5C ). Likewise, Hand1 expression in the LV and AVC was severely compromised as early as 8.25 dpc, with low expression evident only in the AVC ( Figure 5D ). These findings demonstrate the acute sensitivity of some chamber genes to loss of Nrg1 at early stages of heart development and demonstrate further a key requirement for Nrg1 in maintaining the integrity of the cardiac GRN.
Cardiac Gene Expression in Nrg1 ؊/؊ and ErbB4 ؊/؊ Hearts
The morphological phenotype of Nrg1 TM/TM hearts resembles that reported for null alleles of Nrg1 and its receptor chain genes ErbB2 and ErbB4. 14 However, as discussed, our mutation of the Nrg1 TM domain potentially allows for expression of directly secreted splice isoforms. To test genetically whether the Nrg1 TM allele was fully null, we assessed the expression of a subset of diagnostic markers in Nrg1 Ϫ/Ϫ hearts. The Nkx2-5 pattern at 10.5 dpc in Nrg1 Ϫ/Ϫ hearts was identical to that in Nrg1 TM/TM hearts, showing downregulation in the LV but robust expression at the inner curvature, RV, AVC, and atria ( Figures 3D and 5E ). Nppa expression was also very similar in Nrg1 Ϫ/Ϫ and Nrg1 TM/TM embryos, including pronounced upregulation in the atria (Online Figure IV, C) . By contrast, Myl2 expression was more severely affected. As shown above, Myl2 is normally expressed in the ventricular region of 9.5 to 10.5 dpc embryos at both the inner and outer curvatures, with expression in Nrg1 TM/TM hearts at 10.5 dpc downregulated only at the outermost region of the LV ( Figure 3F ). In Nrg1 Ϫ/Ϫ hearts at 9.5 dpc, however, Myl2 expression was lost almost completely from both left and right ventricles, including the inner curvature and AVC ( Figure 5F ). In earlier 8.5 dpc Nrg1 Ϫ/Ϫ embryos, Myl2 expression was lost in working myocardium of both the LV and RV but retained at the inner curvature and interventricular region (Online Figure IV, D) . These findings demonstrate that Nrg1 TM/TM embryos, although severely affected, are not fully null for Nrg1 signaling. They also demonstrate a highly dynamic aspect to the way in which the cardiac GRN fails in Nrg1 mutants.
In addition to multiple neuregulins, other EGF-like signaling ligands function through ErbB receptors, including transforming growth factor-␣, amphiregulin, heparin-binding EGF, ␤-cellulin, and epiregulin. No cardiac phenotype was seen in mutants for Nrg2 or ska (a hypomorphic allele of Nrg3). 37, 38 Nevertheless, to assess redundancy in this system, we exploited a mutant mouse line (ErbB4 gt ) in which the ErbB4 gene had been disrupted by insertion of a gene trap vector. 21 Among EGF family receptors, only ErbB4 and its coreceptor ErbB2 are expressed in developing myocardium, and knockout mice for ErbB4 show the same smooth-walled ventricular chamber phenotype as seen in Nrg1 Ϫ/Ϫ and Nrg1 TM/TM embryos. All signaling from EGF/Nrg family ligands to the myocardium should therefore be blocked in ErbB4 mutants. At 9.5 dpc, expression of both Nkx2-5 and Myl2 was identical in ErbB4 gt/gt and Nrg1 Ϫ/Ϫ hearts (Online Figure IV , E and F). We also noted trabecular rudiments in the RV of ErbB4 gt/gt hearts (Online Figure IV, G) . These features demonstrate that the molecular and morphological status of hearts is identical in ErbB4 gt/gt and Nrg1 Ϫ/Ϫ mutant and that Nrg1 is the predominant EGF/Nrg family member that supports the cardiac GRN in vivo.
Dose-Dependent Responses of Myocardium to Nrg1 In Vitro
Our genetic data show that the cardiac GRN is supported by Nrg1 in the ventricular region in a dose dependent fashion. In an attempt to replicate findings in vitro, we isolated a single cell suspension from 12.5-dpc mouse ventricles, removed fibroblastic cells by serial preplating, and then cultured remaining cardiomyocytes in serum-free medium with increasing doses of soluble recombinant human Nrg1␤2. At low doses (10 Ϫ11 and 10 Ϫ12 mol/L), Nrg1␤2 stimulated DNA synthesis ([ 3 H]-thymidine incorporation) and cell division, although these increases were reversed at progressively higher doses ( Figure 6A and 6B ). Insulin-like growth factor (IGF)1, which can stimulate cardiomyocyte growth and synergize with Nrg1 in a simulated model of trabeculation, 12 also stimulated DNA synthesis and cell division, although there was less attenuation of these parameters at higher doses. The different intracellular signaling responses to low (10 Ϫ10 mol/L) or high (10 Ϫ8 mol/L) dose Nrg1␤2 were seen in the degree of ErbB2/4 receptor phosphorylation after a 10 minutes pulse ( Figure 6C ). Nrg1-ErbB2/4 signaling activates the Erk1/2 MAPK signaling pathway 15 ; a low dose of Nrg1␤2 induced an early but transient spike of Erk1/2 activity, which returned to basal levels within 3 hours ( Figure 6E) , whereas a high dose of Nrg1 activated Erk1/2 signaling in a sustained fashion. This was also seen for Nrg1 and IGF-1 combined, but not with IGF1 alone. These activities are consistent with the known ability of receptor tyrosine kinase-stimulated MAP kinase signaling to respond in both a monostable (proportional) or bistable (all-or-none) manner. 39 Additional biochemical analyses demonstrated that a high dose of Nrg1 led to accumulation of the cyclin-dependent kinase inhibitor p21 CIP1 in an Erk1/2-dependent manner, and inhibition of the activity of cyclin-dependent kinase cdk4, likely accounting for the attenuation of cell proliferation ( Figure 6D and 6E ). Increased levels of cdk inhibitor p21 CIP1 have been associated with cardiomyocyte differentiation and myofibrillogenesis. 40 Nrg1 also stimulated myofibrillogenesis in a dose-dependent and Erk1/2-dependent manner (Figure 6D) . These data show that ventricular myocytes respond in a graded fashion to increasing Nrg1, with higher doses stimulating sustained ERK1/2-p21 CIP1 activity, promoting differentiation at the expense of proliferation.
Nrg1 Stimulates the Cardiac Transcriptional Program in an Erk1/2-Dependent Manner
We therefore examined the relationship between Nrg1-Erk1/2 signaling and the cardiac transcriptional program using an embryo culture assay. The trunk region of wild-type 8.5 dpc embryos was explanted and cultured in low (0.5%) fetal bovine serum medium with or without 10 Ϫ8 or 10 Ϫ9 mol/L Nrg1␤2 for 24 hours. Consistent with previous findings, 25 in situ hybridization and quantitative RT-PCR showed that cardiac markers were significantly downregulated during culture ( Figure 7A through 7C) , a possible effect of cardiac unloading. By in situ hybridization, expression of chamber-restricted genes Nppa and Cited1 was stimulated by Nrg1, and this was attenuated by the MEK inhibitor U0126 (50 mmol/L), demonstrating dependence on the Erk1/2 pathway ( Figure 7A and 7B ). Nrg1-stimulated upregulation of Nppa and Cited1 occurred in the correct spatial pattern for these genes, and the induced expression of Cited1 at the outer curvature of the RV ( Figure 7B ) anticipated its normal expression there at later stages. Changes for Nppa and Cited1, and similar changes for other chamber markers Smpx, Myl2, and Irx4, were documented by quantitative RT-PCR ( Figure  7C ; nϭ6 embryos/probe). Pan-myocardial genes Nkx2-5, Actc1, and Myl7 were also stimulated by Nrg1. Interestingly, Nrg1 stimulation of Myl2, Actc, and Myl7 appeared completely or partially refractory to U0126, suggesting involvement of other downstream Nrg1 pathways for some genes.
High Phospho-Erk1/2 Levels in Chamber Myocardium are Nrg1-Dependent
Finally, we asked whether we could visualize Nrg1-dependent Erk1/2 activity directly in embryos using antibodies to the phosphorylated forms of Erk1/2. At 10.0 dpc, phosphorylated Erk1/2 (pErk1/2) staining was seen across the myocardium ( Figure 8A) . However, the highest levels and in particular levels of nuclear-localized pErk1/2, indicative of sustained Erk1/2 activation, 41 were evident in chamber myocardium of the LV, RV and atrial appendages, with highest overall levels in the LV (Figure 8A and 8D; Online Figure V, A) . Expression in Nrg1 TM/ϩ hearts was diminished although a similar regional pattern was observed ( Figure 8B and 8E; Online Figure V,  A) . In Nrg1 TM/TM hearts, however, expression of pErk1/2 and prevalence of nuclear-localized pErk1/2 were strongly diminished in chamber myocardium ( Figure 8C and 8F; Online Figure V, A) .
To consolidate this finding, we assessed the pErk1/2 pattern in Nrg1 TM and control embryos at stages before trabeculation. At 8.0 dpc, when chamber markers are first activated, highest pErk1/2 levels were seen in the future chamber myocardium located ventrally in the heart tube, and in some surrounding tissues including ventral foregut and second heart field (Online Figure V, B) . In Nrg1 TM/TM mutants, pErk1/2 levels in myocardium, as well as foregut and second heart field, were reduced virtually to background levels, whereas other regions were unaffected. At 9.0 dpc, there was also a pronounced diminution in mutants of the high levels of phosphorylated Erk1/2 found in both future RV and LV myocardium (Online Figure V, C) . These data show that high pErk1/2 expression in the developing heart chambers is Nrg1-dependent. Notably, the LV, which shows the greatest sensitivity in its myogenic program to loss of Nrg1, displayed the highest levels of Nrg1 signaling activity.
Discussion
Previous genetic data have shown that the Nrg1-ErbB2/4 signaling axis plays a key role in cardiac chamber differentiation and trabeculation in the developing embryo. 15 We demonstrate here using Nrg1 and ErbB4 mutant mice that Nrg1 signaling is essential for maintenance of the cardiac GRN in both trabecular and nontrabecular myocardium. The expression of individual genes was downregulated in a manner unrelated to known patterning boundaries, and with individual thresholds and dy-namic region-specific behaviors that betray a previously undiscovered quality of cardiac gene regulation.
At least 31 Nrg1 isoforms are created by differential promoter usage and gene splicing, with most containing the TM domain. 14 Diffusible Nrg1 isoforms, generated either by ectodomain processing or direct secretion, are the active component in cardiac muscle development. Our genetic modification to Nrg1 was designed to test whether artificial Nrg1 isoforms lacking both the TM and intracellular C-terminal domains, and thus resembling the natural I␣/␤ and III␤3 isoforms, which may be directly secreted or intracellular, 28 could substitute for TM isoforms in cardiogenesis. In addition to being required for membrane tethering, the TM domain may be involved in intracellular processing and glycosylation, and intracellular domains are needed for ectodomain shedding. 14 We found that Nrg1 TM/TM mutant hearts resembled the Nrg1 Ϫ/Ϫ null hearts in virtually all aspects of the anatomic and molecular phenotype examined. However, they continued to express the ventricular regionspecific marker Myl2 (severely downregulated in Nrg1 Ϫ/Ϫ null hearts), betraying residual Nrg1 activity, possibly because of low levels of naturally secreted or engineered isoforms. We, therefore, consider Nrg1 TM/TM mutants to be extreme hypomorphs, close in phenotype to null mutants, and that regulated ectodomain shedding of TM domain isoforms is essential for heart development. Without appropriate antibodies to detect secreted isoforms, it remains unclear as to the exact nature of the low Nrg1 activity in hypomorphs.
We have shown genetically that Nrg1 executes at least part of its function through support of the cardiac GRN across the ventricles and flanking regions in a dose-dependent manner. By far the highest level of Nrg1 signaling in the early heart, assessed by pErk1/2 staining, was in ventricular and atrial chamber myocardium. High Nrg1 signaling in these regions likely provides a key stimulus for enhancing myogenic and Purkinje fiber differentiation as the heart matures structurally and functionally. However, how this is linked to cell behaviors in trabecular morphogenesis is currently unknown.
Embryo culture studies demonstrate that Nrg1-Erk1/2 signaling stimulates chamber gene expression, whereas studies in fetal cardiomyocytes show that high Nrg1 signaling promotes myofibrillogenesis and cell cycle withdrawal through enhancing levels of the cell cycle inhibitor p21 CIP1 and suppressing cdk4 activity. Lower Nrg1 signaling stimulated DNA synthesis and cell division, as seen in other in vitro studies 24 and different responses to a graded Nrg1 signal may be a feature of trabecular growth. In the developing heart, Bmp10 also provides a proliferative stimulus for trabecular growth balanced against the dominant prodifferentiation stimulus of Nrg1. 13 Bmp10 was downregulated in Nrg1 TM/TM mutants, likely the result of a compromised transcriptional program.
Marker analyses in mutant embryos suggest that Nrg1 signaling is not required for the initial stages of chamber specification and in embryos cultured in Nrg1, upregulation of chamber genes occurred only in their normal expression domains. Tbx2 was expressed normally in Nrg1 mutants, and this gene likely limits the prodifferentiation activity of Nrg1 toward chamber myocardium. Nonetheless, Nrg1 has a very early role in inducing and/or supporting chamber development, because a block to activation of transcription factor genes Hand1 and Cited1 was observed in early Nrg1 TM/TM hearts before trabeculation. The Hand1/2 genes are essential for growth and differentiation of heart chambers, and Cited1 lies genetically downstream of Hand1. 36 Activated pErk1/2, positioned downstream of Nrg1 signaling, was also severely compromised in chamber myocardium and adjacent noncardiac tissues in Nrg1 TM/TM mutants from as early as 8.0 dpc. We conclude that Nrg1 signaling augments chamber induction and is essential for full chamber specification. The overall phenotype of Nrg1 mutants may be buffered somewhat by the persistence of functional levels of transcription factor proteins beyond the point of GRN collapse at the transcript level, as shown for Nkx2-5 (Online Figure VI) .
The most challenging aspect of the Nrg1 mutant phenotype is to explain the spatiotemporal pattern of decay of individual cardiac genes. We consider these decay patterns to be fundamentally relevant to the function of Nrg1 in cardiogenesis, and not a trivial consequence of embryonic demise because: (1) changes in pErk1/2 and gene expression in mutants occurred very early in chamber development, before trabeculation; (2) heterozygous embryos showed molecular and anatomic features midway between wild-type and homozygous hearts, including the putative stress response in the atria; (3) decay in gene expression was unique to the heart and was not seen at extracardiac sites of expression; (4) expression of the fifteen genes analyzed decayed with a unique set of spatiotemporal signatures; and (5) in wild-type embryos cultured in recombinant Nrg1, chamber genes were induced in a Erk1/2-dependent manner.
Our study shows that, once established, the cardiac GRN in the ventricular region is fundamentally unstable and requires maintenance through extrinsic signaling input from the endocardium. The Nrg1-ErbB2/4-Erk1/2 signaling axis is an essential component of this process. Self-maintenance of the cardiac network is therefore acquired dynamically and is dependent on extracellular signaling context.
It is evident from our study that Nrg1 maintains the cardiac GRN in the ventricular region in both trabecular and flanking nontrabecular myocardium of the inner curvature and AVC. This new insight challenges the prevailing view of Nrg1 signaling in the myocardium: although it is known that Nrg1 signaling is essential for trabecular and Purkinje fiber development, it likely does this through a more global and graded role in the regulation of cardiomyogenic transcription factor gene expression across the ventricular region and perhaps the whole heart. Nrg1 activation of Erk1/2 in cardiomyocytes may converge on the activity of cardiac transcription factors, including Gata4, which are targets of Erk1/2. 42 In Nrg1 mutants, different cardiac genes displayed distinct spatiotemporal decay features that are unrelated to known patterning boundaries in the heart. The most sensitive region for loss of gene expression was the central or outermost region of the LV, in which the GRN underwent complete collapse. This was followed in graded sequence by the outermost region of the RV, the atria, then inner curvature and interventricular region, in which more limited subsets of genes were affected. Individual genes showed complex behaviors that nonetheless adhered to the common pattern. For example, Myl2 transcripts were lost from the outer curvature of the LV at 10.5 dpc in Nrg1 TM/TM embryos but at the outer curvature of both LV and RV in Nrg1 Ϫ/Ϫ -null embryos at an earlier stage (8.5 dpc) and were lost completely in such embryos by 9.5 dpc.
Clues to the molecular mechanism underpinning these patterns come from our analysis of Nrg1 signaling levels in developing hearts. Using pErk1/2 levels as surrogate readout for the intensity of Nrg1 signaling, the graded distribution of pErk1/2 signaling levels correlates with the graded distribution of sensitivity of the cardiac GRN to genetic modulation of Nrg1. There is accumulating evidence that cardiac chamber growth and trabeculation, and Purkinje fiber development in particular, are dependent on hemodynamic forces, 43 reflecting an essential environmental or epigenetic input. Specifically, reduced ventricular loading by atrial ligation or inhibition of mechanosensation, results in delayed maturation of ventricular conduction, whereas increased loading induced by outflow tract constriction led to premature apex-to-base activation (reviewed by Sedmera et al 32 ). Production of endothelin-converting enzyme-1 in the chick endocardium is responsive to biomechanical parameters, leading to cleavage of proendothelin-1, signaling by mature ET1 to G proteincoupled receptors expressed in myocardium, and to induction of Purkinje fiber formation. 44 Indeed, other studies in diverse models link cardiac functional and blood flow parameters to cardiomyocyte, chamber, valve, conduction system and vascular development. 7, 43, [45] [46] [47] In humans hypoplastic left heart syndrome, a severe congenital malformation typified by underdevelopment of left-sided heart structures, is thought to arise from flow defects. 48 Nrg1 expression in endocardium lies downstream of Notch1 and EphrinB2. 13 Although it is not known whether Nrg1 or other components of this pathway are controlled by biomechanical forces, Nrg1 can be induced by ET1 in endothelial cells, and both ET1 and Nrg1 can induce a Purkinje-like phenotype in cultured embryonic cardiomyocytes, stimulating genes such as Nkx2-5 , Hopx (encoding HOP), Sp4 (encoding HF1-b), Kcne1 (encoding Mink), Gja1 (encoding connexin 45), and Gja5 (encoding connexin 40). 17, 49 Our data, which analyzed a subset of these genes in gain-and loss-of-function experiments, is entirely consistent with this study. Crosstalk between tyrosine kinase and G protein-coupled receptors (that act downstream of ET1) is also well documented, as is an interaction between ErbB and integrin receptors (reviewed by Pentassuglia and Sawyer 15 ). We propose that Nrg1-ErbB2/4-Erk1/2 activity in the developing heart forms a vital part of a function/form feedback loop. Production of Nrg1 isoforms may also be responsive to biomechanical forces, although alternatively could act to amplify endothelin-converting enzyme 1-ET1 or mechanosensitive pathways through integrins. We show here that Nrg1 signaling supports the cardiac chamber-specific GRN at the level of its core cardiac transcription factors. The loop critically involves the endocardium, where Nrg1 is expressed. Graded Nrg1 support for the cardiac GRN would account for the graded transmural expression of transcription factor genes and downstream modules in normal development, and, reciprocally, the graded patterns of decay of the network under conditions of reduce Nrg1. We propose that decay patterns reflect regions of highest wall stress and highest Nrg1 signaling. Although cardiac architecture and associated flow and conduction patterns likely restrict wall stress to trabeculated myocardium, our data suggest that a greater region of myocardium, including minimally nontrabecular components of the inner-curvature and AVC, is nonetheless part of a functional and biomechanical continuum under Nrg1 control. These studies suggest a paradigm for understanding how biomechanical forces shape the developing heart and how hemodynamic efficiencies implicit in heart form and function are generated by function itself. It seems evident that many cardiac congenital malformations, not only severe examples such as hypoplastic left heart syndrome, will be caused or compounded by altered feedback signaling between function and form in the developing heart.
